Difference between revisions of "IPS implementationguide 2"

From HL7 IPS
Jump to: navigation, search
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
 
<div class="online-document-information">
 
<div class="online-document-information">
<div class="col-md-12">  
+
    <div class="col-md-12">
<div class="panel panel-warning-white-border">  
+
        <div class="panel panel-warning-white-border">
<div class="panel-heading">
+
            <div class="panel-heading">
<span class="panel-title"><i class="fa fa-cogs"></i> Continuous Build </span>
+
                <span class="panel-title"><i class="fa fa-cogs"/> Continuous Build </span>
</div>  
+
            </div>
<div class="panel-body">
+
            <div class="panel-body">
<p class="bs"></p>
+
                <p class="bs">This is the '''Continuous Build''' of the HL7 CDA® R2 Implementation Guide '''International Patient Summary''' (will be incorrect/inconsistent at times).</p> See the [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=483 Directory of the published standard]. </div>
This is the '''Continuous Build''' of the HL7 CDA® R2 Implementation Guide '''International Patient Summary''' (will be incorrect/inconsistent at times).<p/>
+
        </div>
See the [http://www.hl7.org/implement/standards/product_brief.cfm?product_id=483 Directory of the published standard].  
+
    </div>
</div></div></div></div></div>
+
</div>
  
 
{{Infobox_Document
 
{{Infobox_Document

Revision as of 12:38, 6 August 2024

                Continuous Build 

This is the Continuous Build of the HL7 CDA® R2 Implementation Guide International Patient Summary (will be incorrect/inconsistent at times).

See the Directory of the published standard.
Document Information

This document contains: Standard for Trial Use International Patient Summary (2.00). The text materials belong to category cdaips.